Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
MERTK inhibitor
DRUG CLASS:
MERTK inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
ONO-7475 (3)
UNC2025 (2)
INCB81776 (0)
MRX2843 (0)
PF-07265807 (0)
RXDX-106 (0)
Q702 (0)
SKI-G-801 (0)
ONO-7475 (3)
UNC2025 (2)
INCB81776 (0)
MRX2843 (0)
PF-07265807 (0)
RXDX-106 (0)
Q702 (0)
SKI-G-801 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Melanoma
NRAS mutation
Melanoma
cobimetinib + UNC2025
Sensitive: D – Preclinical
cobimetinib + UNC2025
Sensitive
:
D
cobimetinib + UNC2025
Sensitive: D – Preclinical
cobimetinib + UNC2025
Sensitive
:
D
NRAS mutation
Melanoma
NRAS mutation
Melanoma
UNC2025
Sensitive: D – Preclinical
UNC2025
Sensitive
:
D
UNC2025
Sensitive: D – Preclinical
UNC2025
Sensitive
:
D
MCL1 overexpression
Acute Myelogenous Leukemia
MCL1 overexpression
Acute Myelogenous Leukemia
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
MCL1 S159A
Acute Myelogenous Leukemia
MCL1 S159A
Acute Myelogenous Leukemia
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.